Article

OBJECTIVE: To assess the effectiveness of segmental neuromyotherapy combined with
standard hospital therapy relative to standard therapy alone in patients with
hemiplegic shoulder pain. DESIGN: Randomized controlled trial. PATIENTS: A total
of 24 patients with positive Neer's and hand-behind-neck tests received standard
therapy for shoulder pain.
Half of them received additional segmental
neuromyotherapy. METHODS: Pain severity (visual analogue scale), upper-limb
function (Fugl-Meyer arm score), and spasticity (Ashworth scale) were evaluated
at 2 days (T1) and 1 day (T2) pre-treatment, in the middle (T3) and at the end
(T4) of 4 weeks treatment, and 2 months post-treatment (T5). RESULTS: The
treatment group showed significant advantage compared with the Control group in
Fugl-Meyer scores at T4 (p = 0.014) and T5 (p = 0.0078) compared with initial
values. Significant advantage was also shown in the Neer's test at T4 (p =
0.014), with borderline significance at T5 (p = 0.072).
A larger decrease in pain
scores reported by the treatment group at T5 (p = 0.068) may have been biased by
higher rates of spatial neglect in this group.
CONCLUSION: Segmental
neuromyotherapy added to standard therapy provides an advantage in pain relief
and overall arm function in patients with hemiplegic shoulder pain.

Langue : ANGLAIS